S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82

Global Cord Blood Stock Forecast, Price & News

-0.07 (-1.72%)
(As of 11/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
41,508 shs
Average Volume
185,604 shs
Market Capitalization
$484.99 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CO News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

Global Cord Blood logo

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.


A Look Into Global Cord Blood's Price Over Earnings
November 22, 2021 |  benzinga.com
Generate Life Sciences to be acquired by CooperCompanies
November 10, 2021 |  finance.yahoo.com
Canada Biobanks Market Research Report 2021
November 2, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Miscellaneous health & allied services, not elsewhere classified
Year Founded

Sales & Book Value

Annual Sales
$176.99 million
Cash Flow
$0.67 per share
Book Value
$5.51 per share


Net Income
$77.57 million
Pretax Margin




Free Float
Market Cap
$484.99 million

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

1.28 out of 5 stars

Medical Sector

1160th out of 1,390 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

19th out of 22 stocks

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Global Cord Blood (NYSE:CO) Frequently Asked Questions

How has Global Cord Blood's stock price been impacted by COVID-19?

Global Cord Blood's stock was trading at $4.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CO shares have decreased by 2.0% and is now trading at $3.99.
View which stocks have been most impacted by COVID-19

When is Global Cord Blood's next earnings date?

Global Cord Blood is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Global Cord Blood

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) released its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. Global Cord Blood had a net margin of 41.45% and a trailing twelve-month return on equity of 11.36%.
View Global Cord Blood's earnings history

Who are Global Cord Blood's key executives?

Global Cord Blood's management team includes the following people:
  • Ting Zheng, Chairman & Chief Executive Officer
  • Bing Chuen Chen, Chief Financial Officer & Director
  • Xin Xu, Chief Technology Officer
  • Rui Arashiyama, CEO-Guangdong & Zhejiang Divisions

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

Who are Global Cord Blood's major shareholders?

Global Cord Blood's stock is owned by many different institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (2.52%), Man Group plc (1.46%), BlueCrest Capital Management Ltd (1.20%), Barclays PLC (0.17%), Arrowstreet Capital Limited Partnership (0.16%) and Verition Fund Management LLC (0.07%).
View institutional ownership trends for Global Cord Blood

Which major investors are selling Global Cord Blood stock?

CO stock was sold by a variety of institutional investors in the last quarter, including BlueCrest Capital Management Ltd, Renaissance Technologies LLC, Citadel Advisors LLC, and Millennium Management LLC.
View insider buying and selling activity for Global Cord Blood
or view top insider-selling stocks.

Which major investors are buying Global Cord Blood stock?

CO stock was bought by a variety of institutional investors in the last quarter, including Verition Fund Management LLC, Arrowstreet Capital Limited Partnership, Barclays PLC, Man Group plc, Two Sigma Advisers LP, and American Century Companies Inc..
View insider buying and selling activity for Global Cord Blood
or or view top insider-buying stocks.

How do I buy shares of Global Cord Blood?

Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $3.99.

How much money does Global Cord Blood make?

Global Cord Blood has a market capitalization of $484.99 million and generates $176.99 million in revenue each year. The medical research company earns $77.57 million in net income (profit) each year or $0.64 on an earnings per share basis.

How many employees does Global Cord Blood have?

Global Cord Blood employs 1,260 workers across the globe.

What is Global Cord Blood's official website?

The official website for Global Cord Blood is www.globalcordbloodcorp.com.

Where are Global Cord Blood's headquarters?

Global Cord Blood is headquartered at 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, .

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at (523) 605-8180, via email at [email protected], or via fax at 852-3605-8181.

This page was last updated on 12/1/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.